Video Experimental Relacionado
Updated: Jan 18, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.1K
Consideraciones de sostenibilidad ambiental en la notificación de ensayos clínicos aleatorizados
Florien S van Royen1, Ewoud Schuit2
1Department of General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
The Lancet. Planetary health
|January 15, 2026
Resumen
Los ensayos clínicos aleatorizados (ECA) generan importantes emisiones de carbono. Este estudio encontró que la sostenibilidad ambiental se informa raramente en las publicaciones de ECA, lo que indica la necesidad de una mayor concienciación y estrategias de notificación.
Área de la Ciencia:
- Ciencias Ambientales
- Investigación Clínica
- Salud Pública
Sus antecedentes:
- Los ensayos clínicos aleatorizados (ECA) contribuyen a las emisiones de dióxido de carbono.
- El impacto ambiental del diseño del estudio y las intervenciones en los ECA a menudo se pasa por alto.
Objetivo del estudio:
- Evaluar la notificación de las consideraciones de sostenibilidad ambiental en las publicaciones primarias de los ECA.
- Identificar la medida en que los ECA abordan el uso de recursos, los viajes y el impacto ambiental.
Principales métodos:
- Revisión de 252 ECA publicados en cinco importantes revistas médicas de octubre de 2022 a octubre de 2023.
- Análisis de las publicaciones primarias para detectar declaraciones sobre sostenibilidad ambiental en el diseño y los resultados del estudio.
Principales resultados:
- Solo el 12 % (29/252) de los ECA incluyeron declaraciones relacionadas con la sostenibilidad.
- Apenas el 1,6 % (4/252) hicieron referencia explícita a la sostenibilidad en el diseño o los resultados del estudio.
- Los aspectos de sostenibilidad ambiental se informan con poca frecuencia en las publicaciones de ECA.
Conclusiones:
- Existe una brecha significativa en la notificación de la sostenibilidad ambiental en los ECA.
- Se necesitan estrategias para mejorar la concienciación y la notificación de la sostenibilidad en la investigación de ensayos clínicos.
- La integración de consideraciones ambientales en los ECA es crucial para las prácticas de atención médica sostenible.
Videos de Conceptos Relacionados
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
01:16Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
01:13Randomized Experiments
8.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.9K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144